- Apr 2, 2009
- 5,171
- 13,288
- 67
The US Government Accountability Office has issued an eye popping report exposing the FDA's Center for tobacco Products inner workings and failure to adequately process thousands of Substantial Equivalence (SE) applications filed by tobacco companies since 2010. The GAO report recommends set time frames for the agency's review process of SE applications for tobacco products (as agency has made final decisions on just 19 of more than 4,000 SE applications filed since 2010),
http://www.gao.gov/assets/660/657451.pdf
New Report Highlights Shortcomings in FDA Review Process - Legislative & Regulatory News - Convenience Store News
Senator Burr's press release (as he requested the GAO report)
Richard Burr, United States Senator of North Carolina: Press Releases
This report delineates the same (or very similar) SE application approval/denial process that e-cigarette companies will be forced to comply with if/when the FDA imposes the deeming regulation on e-cigs, as the agency has repeatedly stated its intent to do.
Since a SE or New Tobacco Product application would need to be submitted for every different e-cig product (even slightly different products made by the same company), even if FDA extends the grandfather date from 2007 to 2013 for e-cigs, the deeming regulation would eliminate the vast majority of e-cig products (if manufacturers are required to submit SE applications in 2015 saying their products are substantially equivalent to a product on the market in 2013).
While many e-cig manufacturers (especially small e-liquid manufacturers) market many different e-cig products (all of which would require its own SE application), Altria would only have to submit two SE applications for its two new e-cig products (menthol and nonmenthol).
In essence, the deeming regulation almost certainly would reduce the number of e-cig products on the legal market from more than 1,000 (currently) to no more than a dozen or so (if FDA approves any of the SE applications).
http://www.gao.gov/assets/660/657451.pdf
New Report Highlights Shortcomings in FDA Review Process - Legislative & Regulatory News - Convenience Store News
Senator Burr's press release (as he requested the GAO report)
Richard Burr, United States Senator of North Carolina: Press Releases
This report delineates the same (or very similar) SE application approval/denial process that e-cigarette companies will be forced to comply with if/when the FDA imposes the deeming regulation on e-cigs, as the agency has repeatedly stated its intent to do.
Since a SE or New Tobacco Product application would need to be submitted for every different e-cig product (even slightly different products made by the same company), even if FDA extends the grandfather date from 2007 to 2013 for e-cigs, the deeming regulation would eliminate the vast majority of e-cig products (if manufacturers are required to submit SE applications in 2015 saying their products are substantially equivalent to a product on the market in 2013).
While many e-cig manufacturers (especially small e-liquid manufacturers) market many different e-cig products (all of which would require its own SE application), Altria would only have to submit two SE applications for its two new e-cig products (menthol and nonmenthol).
In essence, the deeming regulation almost certainly would reduce the number of e-cig products on the legal market from more than 1,000 (currently) to no more than a dozen or so (if FDA approves any of the SE applications).
Last edited: